Open access · CC-BY
via OpenAlex
Alpha synuclein and inflammaging
Geneviève L Putnam, Robert W. Maitta
Heliyon · 2025 · ▲ 7 citations
Abstract
The α-synuclein protein is an established molecule in Lewy body pathology, especially Parkinson's disease (PD). While the pathological role of α-synuclein (α-syn) in PD has been well described, novel evidence may suggest that α-syn interacts with inflammasomes in response to aging. As age is an inevitable physiological state and is also considered the greatest risk factor for PD, this calls for investigation into how α-syn, aging, and PD could be linked. There is a growing amount of data regarding α-syn normal function in the body that includes involvement in cellular transport such as protein complexes assembly, vesicular trafficking, neurotransmitter release, as well as immune cell maturation. Regarding abnormal α-syn, a number of autosomal dominant mutations have been identified as causes of familial PD, however, symptomatology may not become apparent until later in life due to compensatory mechanisms in the dopaminergic response. This potentially links age-related physiological changes not only as a risk factor for PD, but for the concept of "inflammaging(definition) ". This is defined as chronic inflammation that accompanies aging observed in many neurodegenerative pathologies, that include α-syn's ability to form oligomers and toxic fibrils seen in PD. This oligomeric α-syn stimulates pro-inflammatory signals, which may worsen PD symptoms and propagate chronic inflammation. Thus, this review will explore a potential link between α-syn's role in the immune system, inflammaging, and PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.heliyon.2025.e41981
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Putnam, G.L., & Maitta, R.W. (2025). Alpha synuclein and inflammaging. <em>Heliyon</em>. https://doi.org/10.1016/j.heliyon.2025.e41981
Vancouver
Putnam GL, Maitta RW. Alpha synuclein and inflammaging. Heliyon. 2025. doi:10.1016/j.heliyon.2025.e41981.
BibTeX
@article{genevive2025Alphas,
title = {Alpha synuclein and inflammaging},
author = {Geneviève L Putnam and Robert W. Maitta},
journal = {Heliyon},
year = {2025},
doi = {10.1016/j.heliyon.2025.e41981},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2012
Open access · CC-BY
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
Current Neuropharmacology 2018
Open access · OA
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Neurobiology of Disease 2022
Open access · CC-BY
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Frontiers in molecular neuroscience 2026
Citation only
From dynamic condensates to pathological assemblies: the phase behavior of tau and <i>α</i>-synuclein.
Frontiers in Aging Neuroscience 2019
Open access · CC-BY
Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
PLoS Biology 2010
Open access · CC-BY